INTERNATIONAL MEDICAL CENTER OF BIOMATERIALS PROCESSING AND CRYOSTORAGE PUBLIC International Medical Center of Biomaterials Processing and Cryostorage Public Stock
Equities
GEMA
RU000A100GC7
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 672 RUB | -0.22% |
|
-.--% | -.--% |
| Sales 2021 | 266M 3.03M | Sales 2022 | 255M 2.9M | Capitalization | 10.03B 114M |
|---|---|---|---|---|---|
| Net income 2021 | 137M 1.56M | Net income 2022 | 98M 1.12M | EV / Sales 2021 | 56.2 x |
| Net Debt 2021 | 25.72M 293K | Net Debt 2022 | 176M 2.01M | EV / Sales 2022 | 40.1 x |
| P/E ratio 2021 |
109
x | P/E ratio 2022 |
102
x | Employees | 15 |
| Yield 2021 |
0.87% | Yield 2022 |
1.19% | Free-Float | 99% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.22% |
3 years
601.00
1 250.00
5 years
410.001 250.00
10 years
410.001 250.00
International Medical Center of Biomaterials Processing and Cryostorage PAO, formerly International Medical Center of Biomaterials Processing and Cryostorage AO is a Russia-based company engaged in medical activities within pharmaceuticals industry. The Company specializes in the storage and distribution of cord blood stem cells. The Company sells its products mainly on the domestic market, as well as exports them to Eastern Europe.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 114M | |
| +19.84% | 84.94B | |
| -25.24% | 74.07B | |
| -1.20% | 26.15B | |
| +4.56% | 18.03B | |
| -9.29% | 17.38B | |
| +4.52% | 16.01B | |
| +78.16% | 13.7B | |
| +77.84% | 13.13B | |
| -26.14% | 12.74B |
- Stock Market
- Equities
- GEMA Stock
